A new bill in the California legislature, Assembly Bill 418, introduced by Democrat Jesse Gabriel could bring about the first sales ban on Skittles and other confections that use food additives
Assembly Bill 418 aims to prohibit the manufacture, sale, and distribution of any foods containing the additives red dye no. 3, titanium dioxide, potassium bromate, brominated vegetable oil, and propylparaben.
Other than Skittles, brands being called out for additive use includes Just Born Quality Confections, the manufacturer of Peeps.
The additives listed in Assembly Bill 418 are currently classified as safe by the FDA. However, the European Food Safety Authority’s independent study revealed the additives’ risk to consumers, including asthma, cancer, memory loss, impaired coordination, and behavioral issues. The European Union banned the use of additives along with the import and use of any food products that use them.


FAA Unveils Flight Plan 2026 to Strengthen Aviation Safety and Workforce Development
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change
Obamacare Premiums Set to Double in 2026 as Subsidy Expiration Looms Amid U.S. Shutdown
Special Prosecutor Alleges Yoon Suk Yeol Sought North Korea Provocation to Justify Martial Law
Bank of Korea Downplays Liquidity’s Role in Weak Won and Housing Price Surge
Asian Technology and Chipmaking Stocks Slide as AI Spending Concerns Shake Markets
Shell M&A Chief Exits After BP Takeover Proposal Rejected
Azul Airlines Wins Court Approval for $2 Billion Debt Restructuring and New Capital Raise
China to Add Eli Lilly’s Mounjaro to National Health Insurance in 2025
EU Court Cuts Intel Antitrust Fine to €237 Million Amid Long-Running AMD Dispute
RBA Unlikely to Cut Interest Rates in 2026 as Inflation Pressures Persist, Says Westpac
Bayer’s Stroke Drug Achieves Breakthrough Trial Results, Boosting Market Confidence
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit
Micron Technology Forecasts Surge in Revenue and Earnings on AI-Driven Memory Demand
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease
Robinhood Expands Sports Event Contracts With Player Performance Wagers
Merck Nears Acquisition of Cidara Therapeutics at Significant Premium 



